V. Serraserra et al., THE EFFECT OF NIFEDIPINE AND METHYLDOPA ON MATERNAL CEREBRAL-CIRCULATION, British journal of obstetrics and gynaecology, 104(5), 1997, pp. 532-537
Objective To study how the treatment of severe gestational hypertensio
n affects maternal middle cerebral artery velocimetry. Design Prospect
ive, clinical, descriptive study. Setting John Radcliffe Maternity Hos
pital, Oxford, England. Participants Pregnant and puerperal women who
required acute or chronic antihypertensive treatment with nifedipine (
n = 46) or methyldopa (n = 26), respectively. Methods Transcranial Dop
pler ultrasound examinations of maternal middle cerebral arteries were
performed before and 45 min after nifedipine; and before and 48 hours
after the onset of methyldopa therapy. Blood pressure and heart rate
were also recorded. Main outcome measures Clinical and transcranial Do
ppler changes induced by the antihypertensive medication. Results Bloo
d pressure and middle cerebral artery velocities decreased significant
ly following bath short- and long-acting antihypertensive therapy. Nif
edipine-induced changes were more pronounced and uniform than those fo
und after methyldopa (16.7% and 6.4% decrease in middle cerebral arter
y mean velocity, respectively). The middle cerebral artery mean veloci
ty decrease was independent of changes in the blood pressure or heart
rate. Conclusions Maternal cerebral haemodynamics are influenced by an
tihypertensive treatment. The reduction of middle cerebral artery flow
velocities following administration of nifedipine and methyldopa may
suggest that cerebral vasodilatation is occurring, which is consistent
with the concept that cerebral vasospasm is present in women with pre
-eclampsia. The cerebral vasodilatation could result from a direct eff
ect of the medication on the arteries in question.